Skip to main content

GSA CAPITAL PARTNERS LLP

Position in ORGO — Organogenesis Holdings Inc.

CIK 1362033 LONDON, X0

Position in ORGO

as of Mar 31, 2026 · filed May 8, 2026
Position Value
$369,409
-$622,379 QoQ
Shares Held
155,869
-18.6% QoQ
Ownership
0.121%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2020
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ORGO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $11,914,926 across 21 Drug Manufacturers - Specialty & Generic names.

# Ticker Company Shares Value (USD) Open

All Filings in ORGO

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $369,409 155,869
2025-12-31 $991,788 191,465
2025-06-30 $289,227 79,024
2024-12-31 $1,133,292 354,154
2024-09-30 $2,212,344 773,547
2024-06-30 $2,477,218 884,721
2024-03-31 $1,508,659 531,218
2023-12-31 $1,071,183 261,903
2023-09-30 $1,954,326 614,568
2023-06-30 $2,354,577 709,210
2023-03-31 $1,545,438 725,558
2022-12-31 $547,135 203,396
2022-09-30 $38,844 11,989
2022-06-30 $167,774 34,380
2022-03-31 $97,917 12,850
2020-09-30 $65,099 16,953